SARS-CoV-2 Omicron BA. 5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of …

…, V Milogiannakis, MR Silva, G Walker, AO Stella… - …, 2022 - thelancet.com
Background Genetically distinct viral variants of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) have been recorded since January 2020. The introduction of global …

SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants

F Tea, A Ospina Stella, A Aggarwal… - PLoS …, 2021 - journals.plos.org
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) antibody neutralization
response and its evasion by emerging viral variants and variant of concern (VOC) are …

[PDF][PDF] Long-term persistence of RBD+ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection

…, W Rawlinson, S Turville, A Aggarwal, AO Stella… - Cell reports …, 2021 - cell.com
Considerable concerns relating to the duration of protective immunity against severe acute
respiratory syndrome-coronavirus-2 (SARS-CoV-2) exist, with evidence of antibody titers …

Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia

A Aggarwal, AO Stella, G Walker, A Akerman… - Nature …, 2022 - nature.com
Genetically distinct variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
have emerged since the start of the COVID-19 pandemic. Over this period, we developed …

All-round manipulation of the actin cytoskeleton by HIV

A Ospina Stella, S Turville - Viruses, 2018 - mdpi.com
While significant progress has been made in terms of human immunodeficiency virus (HIV)
therapy, treatment does not represent a cure and remains inaccessible to many people living …

Fibroblast-expressed LRRC15 is a receptor for SARS-CoV-2 spike and controls antiviral and antifibrotic transcriptional programs

L Loo, MA Waller, CL Moreno, AJ Cole, AO Stella… - PLoS …, 2023 - journals.plos.org
Although ACE2 is the primary receptor for Severe Acute Respiratory Syndrome Coronavirus
2 (SARS-CoV-2) infection, a systematic assessment of host factors that regulate binding to …

SARS-CoV-2 Omicron: evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern

A Aggarwal, AO Stella, G Walker, A Akerman… - medrxiv, 2021 - medrxiv.org
Genetically distinct viral variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
have been recorded since January 2020. Over this time global vaccine programs …

[PDF][PDF] Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability

…, KJL Jackson, DB Langley, A Aggarwal, AO Stella… - Immunity, 2021 - cell.com
Viral mutations are an emerging concern in reducing SARS-CoV-2 vaccination efficacy.
Second-generation vaccines will need to elicit neutralizing antibodies against sites that are …

[PDF][PDF] SARS-CoV-2 Omicron variant escapes neutralizing antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescents

…, Z Al-Delfi, A Abayasingam, D Agapiou, AO Stella… - Cell Reports …, 2022 - cell.com
Coronavirus disease 2019 (COVID-19) convalescents living in regions with low vaccination
rates rely on post-infection immunity for protection against re-infection with severe acute …

[PDF][PDF] Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2-specific CD4+ T cell responses

…, B Grubor-Bauk, W Rawlinson, A Aggarwal, AO Stella… - Cell reports, 2022 - cell.com
Understanding the long-term maintenance of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) immunity is critical for predicting protection against reinfection. In an age- …